075586725195  |  设为首页  |  添加收藏
GIMI 2019 GTCA
GIMI 2019 GTCA International Medical Conference agenda
Date: 2019-04-02

深圳市免疫基因治疗研究院于2019.04.20~21在深圳市举办的国际医学会议:2019基因治疗最新进展 (GIMI  2019 GTCA)。此次会议的主题是免疫与基因治疗的最新进展。会议邀请国际资深医学专家,与相关疾病基金会代表作专题报告,讨论最先进的临床研究的转化应用成果,以及病人的迫切需求。 作为深圳市政府的二级事业单位,深圳市免疫基因治疗研究院全力开展与诸多国内外重要医疗机构的创新技术以及临床合作。经由密切的合作,许多难治的重大疾病现在有机会以高效的技术,且具竞争性与普遍性的成本获得治愈或控制。相信每一位参与  GIMI  2019 GTCA人士都能在会议中见到这些顶尖的癌症治疗与罕见病基因治疗的最新战略与技术方案的进展,并做深度交流。 


GIMI 2019 GTCA International Medical Conference will be held during 20-21 April 2019 in Shenzhen, China.  The theme of the Conference is latest clinical breakthrough of Immuno-therapy and Gene-therapy.  Senior clinical professionals and researchers will provide a forum for the most useful combination of advanced clinical research, review of current theory, practice and efficacy.   As a government sponsored institute, GIMI is proud to partner with both domestic and foreign medical centers.   Through the collaboration, many dreadful diseases can be treated and controlled more effectively at much relatively and competitively low prices.  Participants would gain insight into the most effective advances in the treatment and management of carcinogenic malignancies as well as genetic diseases.




GIMI 2019 4/20 Scientific Program

DAY 1: CART Immunotherapy 1:30 – 5:30

Thematic topic: “Revising cancer treatment guideline after CAR2.0”


13:00-13:30 Registration and Opening Ceremony


13:30-13:50  Dr. Yoshiyuki Takahashi, Nagoya Univ.

“CART therapy for pediatric ALL based on NGS MRD: draft of a new guideline”


13:50-14:20 Dr. Biljana Horn, Univ. Florida

The current state of pediatric CART cell therapy in the USA and updates on toxicity grading”


14:20-14:40 Dr. Sangfang Tu, Zhujiang Hospital

The incorporation of CAR2.0 into adult ALL treatment guideline”


14:40-15:00 Dr. Huyong Zheng, Beijing Children’s Hospital

“Gene therapy for pediatric patients in China”


15:00-15:20 Dr. Michael Copeman, Australia

“The current state of novel immunotherapy in Australia”


15:20-15:40 Tea/coffee break, open discussion forum


15:40-16:00 Mr. Ivan Shpurov, Russia

“Current state of cancer and genetic diseases and overview of potential new treatments in Russia”


16:00-16:20 Dr. Paula Nuqui, Philippines

“Current state of cancer and genetic diseases and novel treatment options in the Philippines"



16:20-16:40 Dr. Santosh Kesari, USA

“Combination immunotherapy for the management of solid tumor”


16:40-17:00 Dr. Ichun Cai, Clifford Hospital, China

“Novel immunotherapy for the management of solid tumor”


17:00-17:20 Mr. Fei Hong, China

“The Chinese Foundation of Lymphoma: a patient’s perspective to new immunotherapy”


17:20-17:40 Patient Representatives: Dr. Guan / Mr. Jing / Mr. Feng, China

“New hope for cancer patients - perspectives of patients’ families”


17:40-18:00 Lung-Ji Chang, GIMI

“CAR2.0 update”


18:00-21:00  Welcome Dinner - International Cancer/Gene Therapy Networking

--------------------------------------------------------------------------------------------------------------


GIMI 2019 4/21 Scientific Program

DAY 2: Gene Therapy (Genetic Diseases) 9:00 – 14:00

Thematic topic: 2019 Gene therapy coming of age


9:00-9:20 Dr. Pamela Lee, Hong Kong Univ

Primary Immunodeficiencies in Asia: Needs, Priorities and Opportunities


9:20-9:40 Dr. Seiji Kojima, Nagoya Univ

“Consortium for the treatment of pediatric cancer and genetic diseases in Asia”


9:40-10:00 Dr. Yuan Sun, Jingdu Children Hospital

“The current state of genetic diseases in China”


10:20-10:40 Dr. Coy Helderman, Univ Florida

“The current state of genetic diseases in the USA”


10:40-11:00 Tea/Coffee Break – Open Discussion Forum


11:00-11:20 Dr. Wuh-Liang Hwu, National Taiwan Univ

Design a gene therapy strategy for AADC deficiency”


11:20-11:40 Dr. Methichit Wattanapanitch, Mahidol Univ

iPSCs and applications in adoptive immunotherapy


11:40-12:00 Shih-Ting Tsao, GIMI

“The first treated CGD patient in Asia using lentiviral CYBB-modified HSCs”


12:00-12:20 Dr. Yoshikazu Nakamura, Japan Foundation for Leukodystrophy

The hope for new treatment from patient point of view


12:20-12:40 Dr. Manish Singh, USA

“The return of gene therapy era – an industrial perspective”


12:40-13:00 Dr. Lung-Ji Chang, GIMI

Closing Remarks


13:00-14:00  Working Lunch / International Gene Therapy Networking



地址:深圳市南山区粤兴二道6号虚拟大学园重点实验室平台二层   电话:075586725195   邮箱:ying.deng@szgimi.org

Copyright © 2016 深圳市免疫基因治疗研究院 版权所有 粤ICP备05053610号-1